Dopamine Dynamics in Depression among Adults: Unravelling the Mediating Influence of Phenylalanine and the Moderating Impact of Genetics in Pathophysiological Pathways

Main Article Content

Nuralieva Nargiza
Abida Rasool
Muhammad Asad Ghafoor
Lixin, Zhang
Chang Ming
Rabia Zahid
Muhammad Masoom Akhtar

Keywords

Mental Resilience Training, Phenylalanine, Genetics, Depression, pathway

Abstract

This meta-analysis presents a systematic exploration of the relationships between phenylalanine, genetics, and depression, focusing on the pathway. A comprehensive literature search, employing a well-defined search strategy, inclusion and exclusion criteria, and date range, identified a total of 423 articles. Through a rigorous screening process, 11 articles originating from meta-analyses were retained for further analysis.


The results reveal significant associations between phenylalanine levels, genetic markers, and depression scores. A nuanced examination of 15 studies, incorporating diverse phenylalanine levels and genetic markers, indicates intricate relationships. The study identifies variations in depression scores corresponding to different phenylalanine levels and genetic markers, emphasizing the complexity of these interactions.


A facet plot visually represents the variation in depression scores across studies, categorized by phenylalanine levels. The analysis suggests potential clinical implications, informing targeted interventions or personalized treatment approaches based on observed associations.


However, the study faces limitations, including heterogeneity among included studies, potential publication bias, and methodological differences. The predominantly adult-focused nature of the studies and the cross-sectional design introduce further constraints.


Looking ahead, the study proposes avenues for future research, encouraging exploration of longitudinal studies, precision medicine, lifestyle and environmental influences, advanced neuroimaging techniques, psychosocial dimensions, and multi-omics data. While recognizing the acknowledged limitations, the meta-analysis contributes valuable insights to the existing knowledge of phenylalanine, genetics, and depression, guiding future research directions and interventions in the pursuit of mental well-being.

Abstract 111 | pdf Downloads 105

References

Ansari, D., Lakkimsetti, M., Olaleye, K. T., Bhullar, J. V. K., Shah, R. Z., Arisoyin, A. E., . . . Abdin, Z. U. J. C. (2023). Genetic Influences on Outcomes of Psychotherapy in Borderline Personality Disorder: A Narrative Review of Implications for Personalized Treatment. 15(8).
Bhatnagar, A., Murray, G., & Ray, S. J. T. i. P. S. (2023). Circadian biology to advance therapeutics for mood disorders.
Bhusal, C. K., Uti, D. E., Mukherjee, D., Alqahtani, T., Alqahtani, S., Bhattacharya, A., . . . Disorders, R. (2023). Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management. 105799.
Blum, K., McLaughlin, T., Bowirrat, A., Modestino, E. J., Baron, D., Gomez, L. L., . . . Cadet, J. L. J. J. o. P. M. (2022). Reward deficiency syndrome (RDS) surprisingly is evolutionary and found everywhere: is it “Blowin’in the wind”? , 12(2), 321.
Brouwer, R. M., Klein, M., Grasby, K. L., Schnack, H. G., Jahanshad, N., Teeuw, J., . . . Gogtay, N. J. N. n. (2022). Genetic variants associated with longitudinal changes in brain structure across the lifespan. 25(4), 421-432.
Corrigan, M., O'Rourke, A. M., Moran, B., Fletcher, J. M., & Harkin, A. J. N. S. (2023). Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin. 7(2).
Han, W., Wang, N., Han, M., Ban, M., Sun, T., & Xu, J. J. F. i. N. (2022). Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options. 16, 1029495.
Hwang, E., Portillo, B., Grose, K., Fujikawa, T., & Williams, K. W. J. M. M. (2023). Exercise-induced hypothalamic neuroplasticity: Implications for energy and glucose metabolism. 101745.
Jiang, Y., Zou, D., Li, Y., Gu, S., Dong, J., Ma, X., . . . Huang, J. H. J. P. (2022). Monoamine neurotransmitters control basic emotions and affect major depressive disorders. 15(10), 1203.
LGFABD, Z. J. J. I. D. E. (2022). The COVID-19 “Bad Tryp” Syndrome: NAD/NADH+, Tryptophan Phenylalanine Metabolism and Thermogenesis like Hecatomb–The Hypothesis of Pathophysiology Based on a Compared COVID-19 and Yellow Fever Inflammatory Skeleton. 8, 243.
Liang, J., Liu, B., Dong, X., Wang, Y., Cai, W., Zhang, N., & Zhang, H. J. F. i. N. (2023). Decoding the role of gut microbiota in Alzheimer's pathogenesis and envisioning future therapeutic avenues. 17, 1242254.
Longo, N., Sass, J. O., Jurecka, A., & Vockley, J. J. J. o. I. M. D. (2022). Biomarkers for drug development in propionic and methylmalonic acidemias. 45(2), 132-143.
Ruiz-Tejada, A., Neisewander, J., & Katsanos, C. S. J. B. S. (2022). Regulation of voluntary physical activity behavior: a review of evidence involving dopaminergic pathways in the brain. 12(3), 333.
Santos-Rebouças, C. B., Cotrin, J. C., dos Santos Junior, G. C. J. M. o. A., & Development. (2023). Exploring the Interplay Between Metabolomics and Genetics in Parkinson's Disease: Insights From Ongoing Research And Future Avenues. 111875.
Thompson, S. M. J. N. (2023). Plasticity of synapses and reward circuit function in the genesis and treatment of depression. 48(1), 90-103.